Open original FDA record ↗Recall record
- FDA identifier
- Z-2478-2026
- Company in FDA record
- MITO RED LIGHT INC
- FDA classification date
- Jun 17, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The near-infrared therapy device contains a lithium-ion battery that may malfunction, causing it to catch fire or burst into flames.
Source facts
- Action
- Beginning on on February 12, 2025, Mito Red Light LLC issued a recall notification to affected consignees in a variety of methods. Mito Red Light is asking consignees to take the following actions: 1. Immediately stop using the mito Mobile Super. 2. Do not charge the device. Disconnect any chargers from the device and rom any power outlet. 3. Store the device away from flammable materials, in a cool dry place, until you can dispose of it. 4. Contact Mito Mobile at 1-866-861-6486 , Email: recall@mitoredlight.com, website: mitoredlight.com/pages/recall to request a replacement device.
- Initiated
- 2025-02-12
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NL, NM, NV, NY, OH, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WI, WV and the countries of Australia, Canada, China, Japan, New Zealand, Spain, Switzerland, United Arab Emirates, United Kingdom.
- Recall number
- Z-2478-2026
- Recall status
- Open, Classified
- CDRH record ID
- 220483
- FDA classified
- 2026-06-17
- Recall event number
- 98999